Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2021-08-13 Regulatory Filings
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release dated August 13, 2021, announcing that Ipsen is withdrawing its approval application for palovarotene with the US FDA and intends to submit a new one after further data analysis. This announcement concerns regulatory interactions, clinical trial data review, and future submission plans regarding a specific drug. This type of communication, which details significant corporate actions related to regulatory processes and clinical development outcomes, fits best under the category of general regulatory announcements or significant corporate news that doesn't align with standard financial reports (10-K, IR, ER) or specific internal management discussions (MDA). Since it is a formal announcement about a regulatory process setback and future plans, and it is not a full financial report, a call transcript, or a specific management/board change, it falls under the broad 'Regulatory Filings' (RNS) category, which serves as a catch-all for important, non-standard announcements. It is not an Earnings Release (ER) or an Interim Report (IR) as it focuses on a regulatory decision, not period results. It is also not a Report Publication Announcement (RPA) because it is the substance of the news, not just an announcement that a report is available.
2021-08-13 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de Commerce and AMF General Regulation) and provides a table detailing the total number of shares and voting rights as of July 31, 2021. This content directly relates to the structure of the company's capital and voting rights, which aligns best with the definition of a filing concerning capital structure changes or related regulatory disclosures. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the most appropriate fit for a regular disclosure detailing the total number of shares and voting rights, as this information is fundamental to capital structure reporting. It is not an earnings release, an AGM material, or a director's dealing report. Given the specific nature of reporting total shares and voting rights, SHA is selected over the general 'RNS'.
2021-08-10 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Monthly information relative to the total number of voting rights and shares composing the share capital' and explicitly references French regulatory articles (AMF). It provides a table detailing the total number of shares and voting rights as of a specific date (July 31, 2021). This content directly relates to the calculation and reporting of voting rights and share capital structure, which is a specific regulatory disclosure. While it is a monthly report, it is not a comprehensive financial report (like 10-K or IR). It most closely aligns with disclosures related to share capital changes or voting rights announcements. Given the options, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit, as it deals directly with the total number of voting rights, even though it is a routine monthly update rather than a post-meeting result.
2021-08-10 English
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document explicitly details a 'Disclosure transaction in own shares' occurring between specific dates (26/07/2021 and 30/07/2021). It provides tables showing the daily volume and weighted average price of shares acquired. This content directly matches the definition for 'Transaction in Own Shares' (share repurchase/issuance), which corresponds to the filing code POS.
2021-08-03 English
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Transaction in Own Shares Classification · 1% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 26 au 30 Juillet 2021" (Declaration of transactions on own shares carried out from July 26 to 30, 2021). The content is a table detailing the volume, weighted average price, and date of transactions involving the company's own shares (share repurchase/issuance). This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document length is short (2207 chars), but it is the report itself, not an announcement of a report, as it contains the detailed transaction data.
2021-08-03 French
Rapport financier semestriel 2021
Interim / Quarterly Report Classification · 1% confidence The document contains comprehensive consolidated financial statements (income statement, balance sheet, cash flow statement) for the first half of 2021 (premier semestre 2021). It includes detailed notes, management activity reports, and auditor reports. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2021
2021-08-02 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.